About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Sarcopenic Obesity in Neurodisabilities

NCT03863379·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Dionyssiotis, Yannis, M.D.

With

University of Athens
University of Patras

Age

20–90

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Persons with
stroke / cerebrovascular disease
traumatic brain injury
multiple sclerosis
spinal cord injuries (including spinal cord lesions i.e. myelopathies etc.)

You may not be if

Persons with
heterotopic ossifications,
chronic administration of drugs, which promote fat increase
chronic administration of drugs, which promote bone or muscle loss
co-existing other diseases such as: endocrinopathies, muscular dystrophies, non-alcoholic fatty liver disease.

The record

StatusCompleted

PhaseNo phase

Taking part150

StartedMay 2019

UpdatedJan 27, 2023

Conditions

Sarcopenic Obesity Spinal Cord Injuries Stroke Multiple Sclerosis Traumatic Brain Injury

Where1

National Rehabilitation Center EKA
Nea Liosia, Athens, Greece

Clareo Health | Sarcopenic Obesity in Neurodisabilities